Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

New Cervical Cancer Screening Guidelines: Rationale and Addressing Barriers to Adoption - Available to ARHP Members Only



This is an internet-based activity that should take 1 hour to complete.

To participate in this webinar learners should:

  • Take the pretest
  • Listen to webinar
  • Take the post-test
  • Complete follow-up evaluation survey

Learning Objectives

At the conclusion of this presentation, participants should be able to:

  • Discuss the epidemiology and natural history of HPV infection and cervical intraepithelial neoplasia
  • Identify the most common genital HPV types in benign and malignant disease
  • Discuss the significance of persistent infection with high-risk HPV type
  • Identify the most common mode of HPV transmission
  • Discuss the 2012 Cervical Cancer Screening Guidelines
  • Discuss barriers to adoption of the guidelines

Accreditation Information

Physicians:

Accreditation
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
ARHP designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others:

A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This webinar is funded by ARHP member dues.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

Barbara J.B. Clark, MPAS, PA-C (Planner) 
Physician Assistant
Knox OB/GYN, Ltd
Ms. Clark is a speaker for Ortho Women’s Health and Urology and Wyeth Pharmaceuticals

Nancy R. Berman MSN, ANP-BC, NCMP (Faculty/Speaker)
Adult Nurse Practitioner/Colposcopist
Certified Menopause Practitioner (NAMS)
The Millennium Medical Group, PC
Ms. Berman is a speaker for QIAGEN, Amgen, and Merck and Co., Inc.; and a member of LabCorp’s Clinical Advisory Board for Women’s Health.

Don Downing, RPh (Planner) 
Clinical Professor
University of Washington School of Pharmacy
Dr. Downing has no affiliations to disclose.

Francisco Garcia, MD, MPH (Planner) 
Associate Professor
Obstetrics & Gynecology, University of Arizona Health Sciences Center
University of Arizona
Dr. Garcia has no affiliations to disclose.

Sherri Sheinfeld Gorin, PhD (Planner) 
Associate Professor of Health and Social Behavior
Columbia University
Dr. Sheinfeld has no affiliations to disclose.

Richard Guido, MD (Planner) 
Associate Professor of Obstetrics/Gynecology & Reproductive Health
Magee Women's Hospital
Dr. Guido conducted research for Graceway Pharmaceuticals and Tigress Pharmaceuticals; speaker for Merck and Co., Inc.; consultant for GlaxoSmithKline

Julie Hibben, LMSW, CPSI (Planner) 
Director of Education and Outreach Planned Parenthood of Greater Iowa

Ms. Hibben has no affiliations to disclose.

Mary Rubin, RNC, PhD, CRNP (Planner) 
Nurse Practitioner
University of California San Francisco
Dr. Rubin is a speaker for Digene Corporation and Merck and Co., Inc.

Marie Savard, MD (Planner) 
Medical Director
Cabrini Missionary Sisters and retirement community, Nursing Home and Long-term Care Facility
Dr. Savard is a speaker for Digene Corporation and GlaxoSmithKline

Anafidelia Tavares , MD (Planner) 
Woman’s Health Initiative Coordinator
New York City Department of Health and Mental Hygiene
Dr. Tavares has no affiliations to disclose.

Maria Trent, MD (Planner) 
Johns Hopkins School of Medicine
Dr. Trent is a speaker for Merck and Co., Inc. Medical Forums.

Thomas C. Wright, MD (Planner) 
Associate Professor of Pathology
Columbia University - College of Physicians 7 Surgeons

Dr. Wright is a consultant for Glaxo Smith Kline, Merck and Co., Inc. and Roche Molecular Systems, Inc.


ARHP Staff/Consultant Disclosures

Camille Harris, MPH
Program Manager
Nothing to disclose

Beth Jordan, MD
Medical Writer
Nothing to disclose

Wayne Shields
President and CEO
Nothing to disclose

Diane Shannon, MD, MPH
Consulting Medical Writer
Nothing to disclose


By clicking this check box, you acknowledge that you have read above information

Back